News & Insights

October 31, 2022
Our Take: Centene to switch PBMs in 2024, awarding new contract to Express Scripts
Read More
October 24, 2022
Our Take: Analysts predict Apple will enter the health insurance market in 2024, Forbes reports
Read More
October 21, 2022
Podcast 153: Overcoming the Costly Roadblocks to Developing Novel Cancer Therapies, with Dr. David Stewart
Read More
October 17, 2022
Our Take: Ransomware attack continues to disrupt business at CommonSpirit
Read More
October 10, 2022
Our Take: Amylyx’s investigational ALS drug gains FDA approval, but the controversy continues
Read More
October 07, 2022
Podcast 152: Tracking the Ever-Changing Life Science Landscape with BioPharmGuy’s Adam Wilson
Read More
October 03, 2022
Our Take: Eisai, Biogen’s lecanemab slowed clinical decline by 27% in Phase III Alzheimer’s trial
Read More
September 26, 2022
Our Take: Humana to acquire primary care centers opened in private equity JV for up to $550 million
Read More
September 23, 2022
Podcast 151: Defragmenting and Rethinking Care Delivery For America’s Aging Adults
Read More
September 19, 2022
Our Take: Physician burnout increased in the pandemic’s second year, survey indicates
Read More
September 12, 2022
Our Take: CVS Health wins bidding contest with offer to acquire Signify Health for approximately $8 billion
Read More
September 09, 2022
Podcast 150: ENCORE Investing in Social Determinants of Health with John Gorman
Read More
August 29, 2022
Our Take: Amazon takes a U-turn and decides to shut down Amazon Care
Read More
August 22, 2022
Our Take: Health systems continue to report dismal financial results in Q2, blunted by labor expenses and poor investment performance
Read More

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Contact Darwin Research Group and we will get right back to you.

Reach out to us

Gainey Corporate Center
8777 N. Gainey Center Drive, Suite 205 Scottsdale AZ 85258
1 (888) 402-3465

News & Insights

Our Take: Centene to switch PBMs in 2024, awarding new contract to Express Scripts

Our Take: Analysts predict Apple will enter the health insurance market in 2024, Forbes reports

Podcast 153: Overcoming the Costly Roadblocks to Developing Novel Cancer Therapies, with Dr. David Stewart

Our Take: Ransomware attack continues to disrupt business at CommonSpirit

Our Take: Amylyx’s investigational ALS drug gains FDA approval, but the controversy continues

Podcast 152: Tracking the Ever-Changing Life Science Landscape with BioPharmGuy’s Adam Wilson

Our Take: Eisai, Biogen’s lecanemab slowed clinical decline by 27% in Phase III Alzheimer’s trial

Our Take: Humana to acquire primary care centers opened in private equity JV for up to $550 million

Podcast 151: Defragmenting and Rethinking Care Delivery For America’s Aging Adults

Our Take: Physician burnout increased in the pandemic’s second year, survey indicates

Our Take: CVS Health wins bidding contest with offer to acquire Signify Health for approximately $8 billion

Podcast 150: ENCORE Investing in Social Determinants of Health with John Gorman

Our Take: Amazon takes a U-turn and decides to shut down Amazon Care

Our Take: Health systems continue to report dismal financial results in Q2, blunted by labor expenses and poor investment performance

Sign up for Our Take
the weekly strategic brief for Health Care Executives

share

Contact Darwin Research Group and we will get right back to you.

Reach out to us

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Stay Connected

News & Insights

Sign up for Our Takethe weekly strategic brief for Health Care Executives

share

Contact Darwin Research Group and we will get right back to you.

Reach out to us

Sign up for Our Takethe weekly strategic brief for Health Care Executives

Stay Connected

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Sign up for Our Take
the weekly strategic brief for Health Care Executives